Asymmetric loss of dopamine transporters in tremor-predominant hemi-Parkinson's disease

被引：0
|
作者：
Shon, YM
Kim, JS
Chung, YA
Lee, KS
机构：
来源：
MOVEMENT DISORDERS | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1075
引用
收藏
页码：S367 / S367
页数：1
相关论文
共 50 条
  • [31] The beneficial effect of salubrinal on neuroinflammation and neuronal loss in intranigral LPS-induced hemi-Parkinson disease model in rats
    Cankara, Fatma Nihan
    Kus, Meliha Sumeyye
    Gunaydin, Caner
    Safak, Sinan
    Bilge, Suleyman Sirri
    Ozmen, Ozlem
    Tural, Emine
    Kortholt, Arjan
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2022, 44 (02) : 168 - 177
  • [32] Tremor in Parkinson's disease inverts the effect of dopamine on reinforcement
    Manohar, Sanjay G.
    BRAIN, 2020, 143 : 3178 - 3180
  • [33] Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
    Fiorenzato, Eleonora
    Antonini, Angelo
    Bisiacchi, Patrizia
    Weis, Luca
    Biundo, Roberta
    MOVEMENT DISORDERS, 2021, 36 (10) : 2303 - 2313
  • [34] Prodromical essential tremor and tremor-predominant LRRK2 mutation Parkinson's disease. Possible optimal VIM DBS results respect to pallidotomy-STN DBS?
    Echebarria Mendieta, S. G.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S172 - S173
  • [35] Striatal dopamine transporters and cognitive function in Parkinson's disease
    Stoegbauer, Jakob
    Rosar, Florian
    Dillmann, Ulrich
    Fassbender, Klaus
    Ezziddin, Samer
    Spiegel, Joerg
    ACTA NEUROLOGICA SCANDINAVICA, 2020, 142 (04): : 385 - 391
  • [36] Imaging of dopamine transporters: Biomarker for progression in Parkinson's disease
    Innis, RB
    Seibyl, J
    Marek, K
    CNS DRUG REVIEWS, 2000, 6 : 33 - 33
  • [37] Parkinson's Disease: Caffeine Intake influences Dopamine Transporters
    不详
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2025, 93 (03) : 75 - 76
  • [38] DBS Programming In Tremor And Akinetic-Rigid Predominant Parkinson's Disease
    Guduru, Z.
    Ginjupally, D.
    Ali, T.
    El Seblani, N.
    Quintero, J.
    Van Horne, C.
    MOVEMENT DISORDERS, 2019, 34 : S355 - S356
  • [39] Effects of piribedil and pramipexole in tremor predominant patients with early Parkinson's disease
    Subutay-Oztekin, N.
    Oztekin, M. F.
    Sari-Polat, R.
    Ak, F.
    MOVEMENT DISORDERS, 2008, 23 (01) : S311 - S311
  • [40] MK801 influences L-DOPA-induced dopamine release in intact and hemi-Parkinson rats
    Jonkers, N
    Sarre, S
    Ebinger, G
    Michotte, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 407 (03) : 281 - 291
12345